Skip to main content

Site notifications

Notice for elasomeran and davesomeran (SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-BA.5) (Moderna Australia Pty Ltd)

Active ingredients
elasomeran and davesomeran (SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-BA.5)
Date of review outcome
Lapse date
Type
Provisional determination
Indication
Booster for active immunisation to prevent COVID-19 caused by SARS-CoV-2
Therapeutic area
Infectious diseases

Help us improve the Therapeutic Goods Administration site